Y.
Wang, C. Wang, C. Wang, M. Zhang, Y. Liu, C. McClain and
W. Feng. Univ. of Louisville and Louisville VA Med. Ctr.
A200
1106.2 S-adenosyl-L-methionine (SAMe) protects
the liver from acetaminophen (APAP) protein modifications
due to oxidative stress.
A.B. Lamyaithong, J.M. Brown, J.G.
Ball, J. Wolfe and M.A. Valentovic. Wheeling Jesuit Univ. and
Marshall Univ.
A201
1106.3 The role of choline depletion in
perfluorooctanesulfonate-induced hepatic steatosis.
P.
Krishnan, A.D. Patterson, D.J. Ehresman, P.B. Smith, M.K.
Scavello, S-C. Chang, J.L. Butenhoff and J.M. Peters. Penn
State and 3M Co.
A202
1106.4 Potentiation of cytotoxicity by two metabolites
of 3-(3,5-dichlorophenyl)-2,4-thiazolidinedione in HepG2 cells.
S. Ejaz, R. Tchao and P.J. Harvison. Univ. of the Scis. in
Philadelphia.
A203
1106.5 Zinc oxide nanparticles induce apoptosis
and necrosis in hepatocellular carcinoma HepG2 cells.
S.M.
Tadinada, M.B. Lai, V. Idikuda, K. Mukka, R.M. Singh, J.
Pfau, A. Bhushan, S. Leung and J.C.K. Lai. Idaho State Univ.
A204
1106.6 The possible antidotal effect of alpha-lipoic
acid against acetaminophen-induced hepatotoxicity in rats.
M.A. El-Moselhy, S.M. El-Shazly and W.A. Barakat. Fac. of
Pharm., Minia Univ. and Zagazig Univ., Egypt.
A205
1106.7 Effects of fluoxetine and aspirin on bleeding
time and liver when used alone or in combination in rats.
S.
Shrestha and N. Sookvanichsilp. Mahidol Univ., Thailand.
A206
1106.8 Induction of neuronal nitric oxide synthase in
livers of mice treated with toxic doses of acetaminophen.
R.
Agarwal, S. Banerjee and J.A. Hinson. Univ. of Arkansas for
Med. Sci.
A207
1106.9 Activation of autophagy by globular adiponectin
attenuates ethanol-induced apoptosis in HepG2 cells.
S. Nepal,
M.J. Kim, A. Subedi and P-H. Park. Col. of Pharm., Yeungnam
Univ., South Korea.
A208
1106.10 Alcohol exposure increases fibroblast growth
factor 21 expression.
C. Zhao, Y. Liu, C. McClain and W. Feng.
Univ. of Louisville and Louisville VA Med. Ctr.
A209
1106.11 Fibroblast growth factor 21 is required for
alcohol-induced adipose tissue lipoatrophy in mice.
Y. Liu, C.
Zhao, Y. Wang, C. McClain and W. Feng. Univ. of Louisville
and Louisville VA Med. Ctr.
PHARMACOLOGY TUESDAY
379
T
U
E
1107. PULMONARY PHARMACOLOGY AND
TOXICOLOGY
Poster
t
ue
. 7:30
am
—B
oston
C
onvention
& e
xhiBition
C
enter
,
e
xhiBit
h
alls
a-B
Presentation time: 12:30
pm
-2:30
pm
A210
1107.1 Olaparib, a PARP inhibitor approved for
human testing, prevents allergen-induced airway inflammation
and hyperresponsiveness in a mouse model of asthma and
reduces proliferation of human CD3/C28-stimulated CD4
+
T
cells.
M.A. Ghonim, A.S. Naura, P. Rodriguez, A. Al Khami,
C. Hernandez, M.S. Mansy, A. Ochoa and H. Boulares. LSU
Sch. of Med., New Orleans and Fac. of Pharm., Al-Azhar Univ.,
Egypt.
A211
1107.2 Validation of an early life candidate biomarker
for childhood asthma.
H. Xu, T. Radabaugh, Z. Lu, D.
Billheimer, D. Vercelli, M. Halonen and S.S. Lau. Univ. of
Arizona.
A212
1107.3 Genetic influences in the development of
amiodarone-induced pulmonary fibrosis.
M. Hartog, B. Herron,
D. Lawrence and X. Ding. New York State Dept. of Hlth. and
Sch. of Publ. Hlth., SUNY at Albany.
A213
1107.4 Acetaminophen at low doses depletes airway
glutathione and alters respiratory reflex responses.
G.J. Smith,
J.A. Cichocki, J.E. Manautou and J.B. Morris. Univ. of
Connecticut.
A214
1107.5 Role of biased signaling by beta-blockers in
the development of asthma phenotype in a murine model.
V.J. Thanawala, G. Forkuo, N. Al-Sawalha, B. Knoll, P. Leff
and R. Bond. Univ. of Houston and Pharmaceut. Consultant,
Cheshire, U.K.
A215
1107.6 Role for A-kinase anchoring proteins in
cigarette smoke-induced barrier dysfunction.
A. Oldenburger,
W. Poppinga, F. Kos, W. Rijks, I. Heijink, W. Timens, H. Meurs,
H. Maarsingh and M. Schmidt. Univ. Med. Ctr. Groningen,
Netherlands.
A216
1107.7 Epac2 and PLC
ε
contribute to the inflammatory
response to cigarette smoke in vivo.
A. Oldenburger, S. Bos,
A. Smrcka, H. Meurs, H. Maarsingh and M. Schmidt. Univ. of
Groningen, Netherlands and Univ. of Rochester Sch. of Med.
A217
1107.8 Effects of dabigatran on bleomycin-induced
pulmonary toxicities and its safety profile in mice.
N. Shrestha
and N. Sookvanichsilp. Mahidol Univ., Thailand.
A218
1107.9 Sphingolipid biosynthesis and inflammatory
signaling in asthma.
S. Ramachandran, A. Engel, G. Barton
and J. Thorner. Univ. of California, Berkeley.
A219
1107.10 Follistatin-like 1 enhances cigarette smoke-
induced interleukin-8 secretion from human airway smooth
muscle cells.
H. Cernecka, W.J. Poppinga, S.R. Jansen, M.
Schmidt, M.J.B. van den Hoff and H. Maarsingh. Univ. of
Groningen, Netherlands and Acad. Med. Ctr., Amsterdam.
A220
1107.11 Therapeutic efficacy of MJ33, a novel inhibitor
of phospholipase A
2
of peroxiredoxin 6, in LPS-induced acute
lung injury.
I. Lee, C. Dodia, S. Chatterjee, S.I. Feinstein and
A.B. Fisher. Univ. of Pennsylvania.
A221
1107.12 Differential expression of renin-angiotensin
system components in the choroid plexus of betamethasone
exposed and control sheep.
A.C. Marshall, H.A. Shaltout, N.T.
Pirro, J.C. Rose, D.I. Diz and M.C. Chappell. Wake Forest
Sch. of Med. and Sch. of Pharm., Alexandria Univ., Egypt.
A222
1107.13 Pharmacological evaluation of Cissus
quadrangularis fractionated extracts for bronchodilatory activity
using guinea pigs.
S.D. Patil and N.K. Kumavat. R.C. Patel
Inst. of Pharmaceut. Educ. and Res., Shirpur, India.
A223
1107.14 Influence of hepatic P450-mediated
amiodarone metabolism on amiodarone-induced pulmonary
toxicity.
M. Hartog, Y. Zhu, D. Lawrence, B. Herron and X.
Ding. New York State Dept. of Hlth. and Sch. of Publ. Hlth.,
Univ. at Albany SUNY.
A224
1107.15 Nerve growth factor reduces amiloride-
sensitive Na
+
transport in human airway epithelial cells.
M.J.
Shimko, E.J. Zaccone, J.A. Thompson, D. Schwegler-Berry,
P.A. Willard and J.S. Fedan. West Virginia Univ. and NIOSH.
A225
1107.16 Effects of popcorn butter flavorings, diacetyl
and 2,3-pentanedione, on isolated airway preparations.
E.J.
Zaccone, J.A. Thompson, M.J. Shimko and J.S. Fedan.
West Virginia Univ. and NIOSH.
A226
1107.17 The role of the
b2-adrenoceptor Gs pathway in
the development of the asthma phenotype in murine models.
G.S. Forkuo, V.J. Thanawala, N. Sawalha, B. Knoll and R.
Bond. Univ. of Houston.
A227
1107.18 Informed target discovery for gene and stem
cell therapy in acute lung injury.
D.Y. Zhou, H. Amatullah, Y.X.
Shan, P. Gali, P.Z. Hu and C.C. dos Santos. Univ. of Toronto.
A228
1107.19 Losartan improves impaired vascular and
endothelial responses in mice with allergic asthma.
D.S.
Ponnoth and S.J. Mustafa. West Virginia Univ.
Are you Tweeting about
EB 2013?
To Tweet use #EB2013
Be sure to follow EB on Facebook
and Twitter
.
POSTER PRESENTERS:
UPLOAD YOUR POSTER
Where: E-Poster Counter, Sun. – Tue. Hall A;
Wed. Hall C
Deadline: Tue., April 23, 5:00
pm
Wed., April 24, 3:00
pm
Uploaded posters will be available online to
all registered attendees following the meeting
at www. experimentalbiology.org
TUESDAY PHARMACOLOGY
380
Physiology
B11
1109.2 Metabolic reprogramming and miRNA
expression profile in liver of prenatally dexamethasone-treated
rats.
L.C. Pantaleão, L.R.B. Santos, L. Sakamoto, C. Lellis-
Santos, P.R.L. Gomes, S.C. Rodrigues, M.Q. Latorraca and
S. Bordin. Univ. of São Paulo and Fed. Univ. of Mato Grosso,
Brazil.
B12
1109.3 Methyl-
b-cyclodextrin increases GLUT4-
mediated glucose transport in skeletal muscle fibers from
insulin-resistant mice.
P. Llanos, A. Contreras-Ferrat, C.
Osorio-Fuentealba, A. Espinosa, J. Hidalgo, C. Hidalgo and
E. Jaimovich. Univ. of Chile, Chile and ICBM, Santiago.
B13
1109.4 The upregulation of skeletal muscle
inflammatory genes links inflammation with impaired insulin
resistance in women with the metabolic syndrome.
M.T.E.
Hopman, G. Lammers, F. Poelkens and C.J. Tack. Radboud
Univ. Nijmegen Med. Ctr., Netherlands.
B14
1109.5 Obesity and insulin resistance in adolescents:
impact of renin angiotensin system.
F.B. Fernandes, A.B.
Fernandes, A.C. da Silva Febba, M.S. de Souza Vitale, F.F.
Jung and D.E. Casarini. Fed. Univ. of São Paulo, Presbyterian
Mackenzie Univ. and Camilo Castelo Branco Univ., Brazil.
B15
1109.6 Induced pulp lesion promotes alteration of the
insulin signal and causes insulin resistance.
D.H. Sumida, R.D.
Astolphi, M.M. Curbete, F.Y. Chiba, A.P. Yamamoto, A.K.C.
Prieto and L.T.A. Cintra. São Paulo State Univ., Araçatuba.
B16
1109.7 Chronic treatment with NaF promotes
dyslipidemia in rats.
D.H. Sumida, C.A.S. Garbin, N.H.
Colombo, R.D. Astolphi and F.Y. Chiba. São Paulo State
Univ., Araçatuba.
B17
1109.8 Effect of milk consumption and the glycemic
response on healthy college aged subjects.
T.M. Fodstad, K.C.
Ackermann and T. Wilson. Winona State Univ.
B18
1109.9 BXD mouse lines as a genetic reference
population for metabolic syndrome.
S. Lamy. EPFL, Lausanne.
B19
1109.10 Muscle-specific deletion of mTORC2 (Rictor)
blocks insulin stimulated Akt Ser 473 phosphorylation and
impairs submaximal but not maximal insulin induced glucose
uptake.
M. Kleinert, L. Sylow, T.E. Jensen, A-J. Oxboll and E.
Richter. Univ. of Copenhagen.
1110. RENAL HEMODYNAMICS AND GFR
Poster
t
ue
. 7:30
am
—B
oston
C
onvention
& e
xhiBition
C
enter
,
e
xhiBit
h
alls
a-B
Presentation time: 12:45
pm
-3:00
pm
B20
1110.1 Rho kinase inhibition counteracts tyrosine
kinase inhibitor-induced rise in arterial pressure and renal
vascular resistance.
O. Grisk, T. Meissner, A. Donner, D.
Braun, U. Zimmermann and R. Rettig. Univ. of Greifswald,
Germany.
B21
1110.2 Acute renal medullary interstitial infusion of
either saline or 2% albumin indistinctly rises RIHP and RMBF
in the rat.
M.E. Sánchez-Briones, J.F. López-Rodríguez,
M.Z. Calvo-Turrubiartes and M. Rodríguez-Martínez.
Autonomuos Univ. of San Luis Potosí, Mexico.
1108. HYPERTENSION III
Poster
t
ue
. 7:30
am
—B
oston
C
onvention
& e
xhiBition
C
enter
,
e
xhiBit
h
alls
a-B
Presentation time: 12:45
pm
-3:00
pm
B1
1108.1 Autophagy in RLVM mediates ER stress-
associated neurogenic hypertension in SHR.
Y-M. Chao, J.Y.H.
Chan and S.H.H. Chan. Chang Gung Mem. Hosp.-Kaohsiung
Med. Ctr. and Natl. Cheng Kung Univ., Taiwan.
B2
1108.2 Decreased transglutaminase activity in aorta
from hypertensive rats, measured by in situ detection of a free
amine donor.
H.G. Petersen-Jones, K.B. Johnson and S.W.
Watts. Michigan State Univ.
B3
1108.3 Effects of ethanol extract of Gastrodia elata
Blume on high-fructose induced metabolic syndrome.
M.C.
Kho, Y.J. Lee, Y.M. Ahn, Y.H. Choi, A.Y. Kim, D.G. Kang and
H.S. Lee. Wonkwang Univ., South Korea.
B4
1108.4 Time course of changes in sympathetic nerve
activity during development of hypertension in spontaneously
hypertensive rats.
N. Mineyama, M. Yoshimoto, M. Shirai and
K. Miki. Nara Women’s Univ. and Natl. Cardiovasc. Ctr., Osaka.
B5
1108.5 The balance between neural and hemodynamic
factors is abolished in hypertensive men.
E. Hart, A. Burchell,
L. Ratcliffe, A. Baumbach, A. Nightingale and J.F.R. Paton.
Sch. of Clin. Sci. and Bristol Heart Inst., Univ. of Bristol.
B6
1108.6 2,4,3´,5´-Tetramethoxystilbene reduces blood
pressure and associated cardiac fibrosis via inhibition of
cytochrome P450 1B1 and decreased oxidative stress in SHR.
B.L. Jennings, D.E. Montanez, A.M. Estes, F.A. Yaghini and
K.U. Malik. Univ. of Tennessee, Memphis.
B7
1108.7 Carotid body denervation stunts development
of Goldblatt 2 kidney-1 clip hypertension in adult rats.
F.D.
McBryde, A.P.L. Abdala, E.B. Hendy and J.F.R. Paton. Univ.
of Bristol.
B8
1108.8 Tissue-specific regulation of CB1/CB2 gene
receptors in salt-sensitive hypertension of SHR.
J. Varagic and
P.E. Gallagher. Wake Forest Univ.
B9
1108.9 Angiotensin II-induced hypertension results in
an oligioclonal T cell receptor expansion in mouse kidney.
D.W.
Trott, C-I. Li, Y. Shyr and D.G. Harrison. Vanderbilt Univ. Med.
Ctr.
1109. DIABETES AND INSULIN RESISTANCE III
Poster
t
ue
. 7:30
am
—B
oston
C
onvention
& e
xhiBition
C
enter
,
e
xhiBit
h
alls
a-B
Presentation time: 12:45
pm
-3:00
pm
B10
1109.1 Effects of aerobic exercise training on obese
female mice: metabolic and autonomic evaluation.
M. Sartori,
L.E. de Souza, P.R. de Souza, F. Santos, K. De Angelis and
M.C. Irigoyen. Heart Inst. and Fac. of Med., Univ. of São Paulo
and Nove de Julho Univ., Brazil.
PHYSIOLOGY TUESDAY
381
T
U
E
B22
1110.3 The
a2-adrenoceptor agonist,
dexmedetomidine, elicits pronounced decreases in arterial
blood pressure and renal hemodynamics in Cyp1a1-Ren2
transgenic rats with angiotensin II-dependent malignant
hypertension.
C.K. Thorngren, M.E. Patterson, P.D. Davis
and K.D. Mitchell. Tulane Univ. and Ochsner Hlth. Syst., New
Orleans.
B23
1110.4 Role of connexin 45 in the autoregulatory
response of the afferent arteriole.
C.M. Sorensen, T.H.
Braunstein and N-H. Holstein-Rathlou. Univ. of Copenhagen.
B24
1110.5 Nephrovascular interactions in a mathematical
model of rat renal autoregulation.
I. Sgouralis and A. Layton.
Duke Univ.
B25
1110.6 Sequential assessment of glomerular filtration
rate during development of hypertension in freely moving Dahl
salt-sensitive rats.
A.W. Cowley, Jr., R.P. Ryan, T. Kurth, D.
Schock-Kusch and N. Gretz. Med. Col. of Wisconsin and Univ.
of Heidelberg, Mannheim.
B26
1110.7 N-acetyl-seryl-aspartyl-lysyl-proline (Ac-
SDKP) prevents the progression of renal dysfunction in mice
with lupus (MRL/lpr).
T-D. Liao, P. Nakagawa, M. D’Ambrosio,
N-E. Rhaleb, X-P. Yang and O. Carretero. Henry Ford Hosp.
B27
1110.8 Resveratrol induces acute endothelium-
dependent renal vasodilation.
K.L. Gordish and W.H.
Beierwaltes. Wayne State Univ. and Henry Ford Hosp.
B28
1110.9 Switch from ACE to chymase mRNA expression
in diabetes in enriched renal vascular tissues harvested by
manual sieving.
S.M. Ford, P.M. Berner and L.M. Harrison-
Bernard. LSU Hlth. Sci. Ctr., New Orleans.
B29
1110.10 The role of nitric oxide in pericyte-mediated
regulation of vasa recta diameter.
C. Crawford, J.S. Pollock,
S.S.P. Wildman and C.M. Peppiatt-Wildman. Medway Sch. of
Pharm., Univs. of Kent and Greenwich, U.K. and Med. Col. of
Georgia.
B30
1110.11 Telemetry-based oxygen sensor to continuously
monitor renal cortical oxygenation in the conscious rat.
M.P.
Koeners, C.P.C. Ow, R.G. Evans, D.M. Russell, J.A. Joles
and S. Malpas. Univ. of Auckland, New Zealand, Univ. Med.
Ctr. Utrecht, Netherlands, Monash Univ., Australia and Millar
Instruments, Auckland.
B31
1110.12 Serine proteases affect in situ vasa recta
capillary diameter: mechanism for kidney failure associated
with pancreatitis?
R. Birch, C. Crawford, M. Kelly, R.J. Unwin,
E. Schwiebert, S.S.P. Wildman and C.M. Peppiatt-Wildman.
Medway Sch. of Pharm., Univs. of Kent and Greenwich, UCL
Med. Sch., Royal Free Hosp., London and DiscoveryBiomed
Inc., Birmingham, AL.
B32
1110.13 A novel role for GABA and glutamate in
pericyte-mediated regulation of medullary blood flow.
K.N.
Dunn, S.P. Kelley, C. Crawford, S.S.P. Wildman and C.M.
Peppiatt-Wildman. Medway Sch. of Pharm., Univs. of Kent
and Greenwich, U.K.
B33
1110.14 Inhibition of NADPH oxidase improves renal
autoregulation in rats fed a high salt diet.
R.C. Fellner, M.I.
Giddens and E.W. Inscho. Georgia Hlth. Sci. Univ.
B34
1110.15 Attenuated contractility in afferent arterioles
during development of proteinuria in two-kidney, one-clip
hypertensive rats.
T.D. Dahl, T. Skogstrand, F. Helle, M.
Hultström, O. Tenstad and B.M. Iversen. Univ. of Bergen,
Norway, Univ. of Uppsala, Sweden and Haukeland Univ. Hosp.,
Bergen.
B35
1110.16 Renal autoregulation dynamics monitored
across the renal surface.
C. Scully, N. Mitrou, B. Braam, W.
Cupples and K. Chon. Worcester Polytech Inst., Simon Fraser
Univ., Canada and Univ. of Alberta.
B36
1110.17 A pivotal role for pericytes in non-steroidal anti-
inflammatory drug-induced toxicity.
C.M. Peppiatt-Wildman,
T. Kennedy-Lydon, C. Crawford and S.S.P. Wildman.
Medway Sch. of Pharm. and Royal Vet. Col., Univs. of Kent and
Greenwich, U.K.
B37
1110.18 Renal ischemia-reperfusion led to enhanced
renal microvascular response to sphingosine-1-phosphate.
Z. Guan, S.T. Singletary, J. Van Beusecum, A.K. Cook and
E.W. Inscho. Georgia Hlth. Sci. Univ.
B38
1110.19 Potential sex differences in the vascular
endothelial growth factor signaling pathway in the kidney.
A.
Rouch and L. Fan. Oklahoma State Univ. Ctr. for Hlth. Sci.
B39
Dostları ilə paylaş: |